The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA Set to Review Peptide Access for Compounding Pharmacies Drug Topics TB500 Bpc 157 Steroid Injection, Color : Transparent, Form : Liquid at Best Price in Nagpur The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what